Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abimbola O Olusanya"'
Autor:
Jane M Wei, Paul Kim, Cheryl Ewing, Jasmine Wong, Laura J Esserman, Michael D Alvarado, Abimbola O Olusanya, Skye Stewart, Ashley Tydon, Parima Daroui, Jeffrey V Kuo, Hannah L Park, Karen T Lane, Eliza Jeong, Kelsey Brown, Ava Hosseini, Barbara A Parker, Sarah L Blair, Athena Breast Health Network Investigators, Frederick Baehner, Olivier Harismendy, Antonia Petruse, Carlie K Thompson, Helena R Chang, Alexander D Borowsky, Christina Yau, Gillian L Hirst, Richard J Bold, Rita A Mukhtar
Publikováno v:
Cancer Research. 80:OT3-09
Background: Ductal carcinoma in situ (DCIS) now represents nearly a quarter of newly diagnosed breast cancers in the United States. Standard-of-care treatment for DCIS is aggressive local therapy consisting of either mastectomy or breast conserving s
Autor:
Abimbola O Olusanya, Chin-Shang Li, Arta M. Monjazeb, Li Yuan Lee, Dariusz Borys, Robert M. Tamurian, Scott D Christensen, Robert D. Boutin, Robert J. Canter
Publikováno v:
Annals of surgical oncology, vol 21, iss 5
BackgroundDespite effective local therapy with surgery and radiotherapy (RT), ~50 % of patients with high-grade soft tissue sarcoma (STS) will relapse and die of disease. Since experimental data suggest a significant synergistic effect when antiangio
Autor:
Emanual Michael Maverakis, Abimbola O Olusanya, Robert J. Canter, Dhruvil R. Shah, Steve R. Martinez, Anthony D. Yang
Publikováno v:
Journal of Clinical Oncology. 30:e19013-e19013
e19013 Background: Sentinel lymph node biopsy (SLNB) was developed for intermediate thickness melanoma. Its use for thick cutaneous melanoma is controversial. We aimed to report on clinical and pathologic factors associated with the overuse of SLNB f
Autor:
Wayne L. Monsky, P. Mack, Robert M. Tamurian, Robert J. Canter, Scott D Christensen, W. Mak, Michael H. Buonocore, Dariusz Borys, A. M. Chen, Abimbola O Olusanya
Publikováno v:
Journal of Clinical Oncology. 28:TPS333-TPS333
TPS333 Background: Despite effective local therapy, patients with locally advanced extremity soft tissue sarcoma (ESTS) are at high risk for distant failure and demise. Novel therapies for this gro...